ArticleBMC public health2026
Association of changes in grip strength with risk of incident cardiovascular disease in middle aged and older adults from the UK biobank.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cross-cohort insights into the association of handgrip strength transitions and burdens with cardiovascular disease risk.SSM - population health · 2026Article
- Cross-cohort insights into the association of handgrip strength transitions and burdens with cardiovascular disease risk.medRxiv : the preprint server for health sciences · 2026Article
- Trajectories of grip strength decline and risk of new-onset cardiovascular disease: evidence from the HRS and ELSA cohorts.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPrevious studies mainly focused on grip strength at a single timepoint, but evidence is scarce on the association between changes in grip strength (HGS) and risk of incident cardiovascular disease (CVD).
methodsThe data were sourced from UK Biobank. HGS was measured by trained staff with calibrated Jamar J00105 hydraulic hand dynamometer. HGS changes were measured by combining HGS at baseline and imaging visit (2014+), defined in three methods below: changes in standardized HGS (reference, decline, stable high, and stable low), changes in dichotomous HGS (normal/normal, weakness/normal, normal/weakness, and weakness/weakness), and annual rate of change in HGS (continuous). The outcome of interest was incidence of CVD. Cox regression was used to examine the association of changes in HGS with risk of CVD incidence.
resultsIn the current study, the mean (SD) age was 54.4 (7.5) years and 47.4% were men among 57,490 participants. For the analysis of changes in HGS with CVD, the median (IQR) interval between baseline and imaging visit was 9.7 (8.0, 11.1) years. Since the time of imaging visit, the median (IQR) follow-up was 3.8 (2.7, 5.3) years, and 4,945 CVD cases occurred. The main findings of changes in HGS and CVD are as follows. (1) For changes in standardized HGS, both “decline” (HR = 1.12, 95% CI: 1.04–1.21) and “stable low” (HR = 1.14, 95% CI: 1.02–1.28) groups had increased risk of CVD incidence, the significance only remained for the “decline” group after further adjusting for frailty phenotypes (FP). (2) For changes in dichotomized HGS, compared with the normal/normal group, participants being “normal/weakness” (HR = 1.19, 95% CI: 1.09–1.30) and “weakness/weakness” (HR = 1.14, 95% CI: 1.04–1.24) had higher risk of incident CVD; but after adjusted for FP, the associations only remained for “normal/weakness” group. (3) Also, per 1-SD decrease in annual rate of change in HGS was associated with 5% (HR = 1.05, 95% CI: 1.02–1.08) increased incident CVD risk whatever adjusted for FP or not.
conclusionsConsistent low and declining HGS was associated with elevated risk of CVD incidence. Maintaining a stable and appropriate level of grip strength was recommended to reduce the risk of CVD incidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.